Skip to Content

Solanbridge Group Inc SLNX

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Solanbridge Group Inc is based in Spring, Texas and is an innovative biotechnology company focusing on research, development, and production of nutraceutical and cosmetic products. The company is into medical marijuana industry, focuses on producing highest quality CBD hemp oil in Colorado, Nevada, and California. Its objective is to develop and offer specifically chosen products based on their effectiveness to manage various aspects of the customer's medical and personal needs.

Contact
9595 Six Pines Drive, Suite 8210
The Woodlands, TX, 77380-1642
T +1 832 225-1372
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Sep 30, 2010
Fiscal Year End Dec 31, 2012
Stock Type Cyclical
Employees